20 results on '"Gómez D"'
Search Results
2. EP16.01-04 Standardized Screening of Thoracic Oncology Patients for Clinical Trial Eligibility Increases Enrollment
3. 169P Phase I dose escalation trial combining olaparib and thoracic radiation therapy in extensive-stage small cell lung cancer
4. P2.12-03 External Validation of a Novel CT-Based Prognostic Radiomic Signature in Patients with Metastatic NSCLC in SWOG S0819 Phase III Randomized Trial
5. P27.02 Associating Cardiac Plaque Accumulation With Cardiac Toxicity and Overall Survival In Locally Advanced Non-Small Cell Lung Cancer
6. P05.01 Personalized Optimization of TCP Using NTCP Based Constraints for Ultracentral Lung Tumors
7. FP09.03 Phase II Randomized Trial to Evaluate Prednisone Taper With or Without Nintedanib for the Treatment of Radiation Pneumonitis
8. MA01.02 Surgical Complexity of Pulmonary Resections Performed for Oligometastatic Non-Small Cell Lung Cancer
9. OA13.01 S1619 A Trial of Neoadjuvant Cisplatin-Pemetrexed With Atezolizumab in Combination and Maintenance for Resectable Pleural Mesothelioma
10. P05.10 Risk Factors Associated with Pulmonary Toxicities from Multiple Courses of Lung Stereotactic Body Radiation Therapy (SBRT)
11. P02.14 Radiotherapy-Associated CT Imaging as a Potential Screening Tool for COVID-19
12. FP04.01 Heart Dose is a Dosimetric Predictor of Overall Survival in Patients with NSCLC Undergoing Post-Operative Radiation Therapy
13. FP04.04 EGFR Mutations Predict Superior Survival of NSCLC Patients with Oligometastatic Disease Treated with Local Consolidative Therapy
14. 230P Experience with the implant of vascular access devices by medical oncologists in a non-surgical setting
15. P2.04-19 Neoadjuvant Chemotherapy Is Associated with Immunogenic Cell Death and Increased T Cell Infiltration in Early-Stage NSCLC
16. ES21.03 Interpreting the Current Data for Local Consolidative Treatment in the Setting of Oligometastatic Disease: Where Do We Stand?
17. P3.01-26 A Framework for Systematic Clinical Evaluation of Technical Innovations in Lung Cancer Patients Treated on the MR-Linac (MRL)
18. P2.04-25 Randomized Clinical Trial Comparing Immunotherapy Plus SABR (I-SABR) Versus SABR Alone for Early Stage NSCLC
19. OA01.06 DETERRED: Phase II Trial Combining Atezolizumab Concurrently with Chemoradiation Therapy in Locally Advanced Non-Small Cell Lung Cancer
20. PC03.02 Post-Operative Radiation Therapy or NOT: CON
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.